Clearmind Medicine
CMND----
Q2 FY2026 Earnings
Financial report interval: 2026.01.30 - 2026.04.30
Overview: Clearmind Medicine(CMND) the EBIT is -1.571 M (-20.22%);the EPS is -6.78 (+89.11%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B20.22%
----
----
EPS
-6.781189.11%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf